Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Definium Therapeutics, Inc. | 115,000 | reported | 03 Feb 2026 | tx 2+465,000 |
| VYNE Therapeutics Inc. | 109,246 | reported | 30 Jun 2021 | tx 18+721,814−13,780 |
| Foamix Pharmaceuticals Ltd. | 78,799 | reported | 09 Mar 2020 | tx 12+312,939−312,939 |
| BioXcel Therapeutics, Inc. | 19,011 | reported | 03 Oct 2024 | tx 16+164,375−9,239 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2026 | GRANT_AWARD | Definium Therapeutics, Inc. | 115,000 | 0.00 USD | |
| 22 Jul 2024 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 1,875 | 0.00 USD | deriv |
| 17 Mar 2025 | GRANT_AWARD | Definium Therapeutics, Inc. | 350,000 | 0.00 USD | deriv |
| 17 Sept 2024 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 21,250 | — | |
| 03 Oct 2024 | SALE | BioXcel Therapeutics, Inc. | 6,272 | 0.55 USD | |
| 15 Sept 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 750 | — | |
| 16 Sept 2024 | SALE | BioXcel Therapeutics, Inc. | 215 | 0.69 USD | |
| 15 Sept 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 750 | 0.00 USD | deriv |
| 17 Jun 2024 | SALE | BioXcel Therapeutics, Inc. | 244 | 1.26 USD | |
| 15 Jun 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 750 | — | |
| 15 Jun 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 750 | 0.00 USD | deriv |
| 15 Mar 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 3,000 | — | |
| 04 Apr 2024 | SALE | BioXcel Therapeutics, Inc. | 1,008 | 2.64 USD | |
| 15 Mar 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 3,000 | 0.00 USD | deriv |
| 15 Mar 2023 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 36,000 | 0.00 USD | deriv |
| 15 Mar 2023 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 17 Jan 2022 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 85,000 | 0.00 USD | deriv |
| 30 Jun 2021 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 5,151 | 3.51 USD | |
| 31 Mar 2021 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 2,573 | 6.84 USD | |
| 22 Feb 2021 | GRANT_AWARD | VYNE Therapeutics Inc. | 27,675 | 0.00 USD | |
| 22 Feb 2021 | GRANT_AWARD | VYNE Therapeutics Inc. | 64,575 | 0.00 USD | deriv |
| 31 Dec 2020 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,541 | 1.58 USD | |
| 30 Nov 2020 | GRANT_AWARD | VYNE Therapeutics Inc. | 7,838 | 1.45 USD | |
| 30 Sept 2020 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,541 | 1.66 USD | |
| 30 Jun 2020 | TAX_WITHHOLDING | VYNE Therapeutics Inc. | 1,541 | 1.73 USD |